Loading organizations...
Fountain Healthcare Partners is a Dublin, Ireland-based venture capital firm that provides capital and strategic support to seed and early-stage life sciences companies operating across Europe and the United States. The firm focuses its investment strategy on specialty pharmaceuticals, biopharmaceuticals, medical devices, and diagnostics, typically leading or co-leading syndicates to drive growth and achieve exits within a three to six-year timeframe. Operating through a traditional fund management model, the organization currently oversees more than €425 million in total assets under management across its various portfolios. The firm recently expanded its financial capacity by closing its third dedicated investment vehicle, which secured €118 million in committed capital under the guidance of key partners like Dr. Ena Prosser and Justin Lynch. Fountain Healthcare Partners was officially founded in 2008 by managing partners Aidan King and Dr. Manus Rogan.
Key people at Fountain Healthcare Partners.
Fountain Healthcare Partners is based in Dublin, Ireland, and also maintains an office in New York, United States.
The firm offers both risk capital and expertise to ambitious entrepreneurs who are building companies within the life sciences industry.
Fountain Healthcare Partners is based in Dublin, Ireland, and also maintains an office in New York, United States.
The firm offers both risk capital and expertise to ambitious entrepreneurs who are building companies within the life sciences industry.
Key people at Fountain Healthcare Partners.
Headquartered in Dublin, Ireland, Fountain Healthcare Partners also maintains an office in New York, United States. This dual geographic presence allows the firm to engage with a broader range of opportunities and talent across different regions, particularly within the European and North American life science ecosystems.
The firm's investment strategy is centered on identifying and supporting ambitious entrepreneurs. By providing both financial backing and operational guidance, Fountain Healthcare Partners seeks to contribute to the successful development of its portfolio companies, helping them navigate the complexities of the life science landscape.
Dr. Manus Rogan, a co-founder and Managing Partner, plays a key role in the firm's leadership. His involvement underscores the firm's commitment to leveraging experienced professionals with deep industry knowledge to guide its investment decisions and support its portfolio.
Fountain Healthcare Partners is dedicated to advancing healthcare through strategic investments. Its focus on life sciences positions it within a sector critical for medical advancements and public health, aiming to back ventures that can deliver significant impact.
Fountain Healthcare Partners has 21 tracked investments across 14 companies. The latest tracked deal is $7.4B Series C in Neurent Medical in February 2026.
